Globus Sensation: The Lump-in-the-Throat Feeling

Globus sensation, also called globus pharyngeus or simply globus, is the feeling of a lump, a tightness or a foreign body in the throat when nothing is stuck there. Food and drink go down normally. The feeling is real, it can be persistent and upsetting, and for many people the worst part is the fear that it means cancer. This page sets out what researchers have found about how the feeling differs from true swallowing difficulty, how common it is, the conditions studied as causes, how doctors investigate it, the treatments that have been tested in trials, and how it tends to change over the years. It goes deeper than the short mentions of globus on the Laryngopharyngeal Reflux and Dysphagia pages.

What Globus Feels Like

People describe globus in many ways: a lump, a pill that never went down, a ball, a tight collar, a crumb or a hair caught in the throat. A Finnish review describes it as a non-painful sensation of a lump or foreign body in the throat that frequently improves with eating. A joint review by the European and American neurogastroenterology and motility societies adds the word "tightness" and notes the same pattern: the feeling is not tied to swallowing difficulty and may actually ease during meals.

That detail matters. When a real obstruction narrows the throat or the food pipe (esophagus), eating is when the trouble shows up, because a mouthful of food has to pass the narrow point. In globus, the feeling is often most noticeable between meals, or when swallowing saliva with nothing else in the mouth, and a meal can make it fade for a while.

Globus has a long and unflattering history. The older name "globus hystericus" reflects the time when it was labelled a hysterical symptom. The Finnish review notes that modern research has moved toward bodily causes and that the cause is now thought to be complex. The name is still found in some papers, including one of the Chinese formula trials described below.

How Globus Differs From True Swallowing Difficulty

Difficulty swallowing (dysphagia) is a different symptom. In dysphagia, food or drink actually has trouble getting through: it sticks on the way down, sets off coughing or choking, or comes back up. The Dysphagia page covers its causes, which include strokes, nerve and muscle diseases and narrowing of the esophagus.

In globus, swallowing works. The definitions used in research leave this point in no doubt. A 2026 study using the Rome IV criteria defines globus as the sensation of a lump in the throat without dysphagia, and without an underlying structural abnormality or a major disorder of esophageal movement. Pain on swallowing (odynophagia) is also outside the picture: the review literature describes globus as painless.

Some people have both symptoms at once, and one does not rule out the other. The joint society review lists dysphagia, pain, pain on swallowing and weight loss among the "alarm" features that lead doctors to objective testing, which is covered in the section on prompt evaluation.

Feature	Globus	Dysphagia
Food and drink pass normally	Yes	No; food sticks, catches or goes the wrong way
Pain	Described as painless	Can be painful, depending on cause
Effect of eating	Often eases during meals	Trouble appears with meals
Weight loss	Not part of the picture	Can occur when eating is hard

How Common Globus Is

Figures vary widely depending on how the question is asked. A brief, passing lump feeling is very common: an Australian general-practice review gives a lifetime prevalence of up to 45% of the population. Persistent globus that meets formal research criteria is much rarer.

The largest measurement comes from the Rome Foundation Global Epidemiology Study, which surveyed 54,127 people over the internet across many countries. Using the Rome IV criteria, the prevalence of globus was 0.75%. It was highest in Western Europe (0.94%) and Asia (0.90%) and lowest in the Middle East (0.31%). Women made up 55.4% of those affected, and the largest group (46.6%) were aged 40 to 64.

Globus is a familiar reason to see a specialist. Long-term follow-up work from Ireland reports that it accounts for 3% to 4% of new ear, nose and throat (ENT) outpatient referrals, and a 2024 American study and the Australian review both give a figure of about 4% of referrals to otolaryngologists.

The Rome IV Definition of Functional Globus

The Rome Foundation publishes criteria for disorders of gut-brain interaction, meaning conditions in which the gut produces real symptoms without a visible disease to explain them. Its fourth edition (Rome IV) places globus among the functional esophageal disorders, a group that covers esophageal symptoms such as heartburn, chest pain, swallowing difficulty and globus when no structural cause is found.

The Rome IV committee describes these disorders as esophageal symptoms that are not explained by three groups of conditions:

Mechanical obstruction: a narrowing (stricture), a tumor, or eosinophilic esophagitis, an allergic inflammation of the esophagus.
Major motor disorders: diseases of esophageal muscle movement such as achalasia, outflow obstruction at the lower end of the esophagus, absent contractions, distal esophageal spasm and the so-called jackhammer esophagus.
Gastroesophageal reflux disease (GERD).

The committee writes that the mechanisms are unclear but that visceral hypersensitivity (nerves in the gut that signal discomfort at a lower threshold than usual) and hypervigilance (heightened attention to body sensations) are thought to play an important role, often in the setting of normal or borderline esophageal function. It reports that treatments aimed at nudging borderline muscle function or reducing reflux below normal levels have had limited success, while strategies that change how signals are triggered and perceived are mechanistically plausible, with limited outcome data.

In practice, "functional globus" is therefore a diagnosis reached after the conditions above have been looked for and not found. The joint society review states that a diagnosis of idiopathic globus requires pharyngeal, laryngeal and esophageal disorders to be excluded.

The 2026 global survey found that globus overlapped more with disorders elsewhere in the gut than with heartburn: coexisting heartburn was reported in 17.4% of cases, another esophageal functional disorder in 9.1%, and a functional disorder outside the esophagus (for example functional dyspepsia) in 49.0%.

Reflux and the Throat

Reflux is the cause studied most often. Two forms are relevant. In gastroesophageal reflux disease, stomach contents come back up into the esophagus, usually with heartburn. In laryngopharyngeal reflux, material reaches the voice box and throat, often with throat clearing, hoarseness and cough rather than heartburn.

The link between reflux and globus is real in some people and absent in others. An American review of 172 people with isolated globus who had several tests found abnormal acid exposure on pH testing in about 20%. A Korean clinic found that 122 of 592 people with globus did not respond to 8 weeks of a proton pump inhibitor, the main class of acid-suppressing drugs. When those people had 24-hour monitoring, they divided into groups with acid reflux, reflux that was not acidic, and no reflux at all. The authors measured the electrical resistance of the esophageal lining and report a pattern they interpret as increased permeability of the lining in globus, a finding they describe as needing larger studies.

Older Irish follow-up work found that the presence or absence of heartburn, or its treatment, had no bearing on how globus turned out. The Rome IV view, which treats globus as functional only when reflux disease has been excluded, reflects the same uncertainty: reflux explains globus for some people, but it is not the whole story.

The Upper Esophageal Sphincter

The upper esophageal sphincter is a ring of muscle at the top of the esophagus, just behind the voice box. It stays closed between swallows and relaxes to let food through. Because it sits roughly where people point when they describe the lump, it has long been a suspect.

A Chinese study used high-resolution manometry, a test that measures pressure along the esophagus with a thin tube, in 42 people with globus and 38 without. In people with globus but no signs of reflux, the average resting and residual pressures of the upper sphincter were higher than in the comparison groups, while the lower sphincter and the body of the esophagus showed no differences. The same group reported stress, smoking, alcohol, high salt intake and anxiety more often. The authors propose that globus without reflux may arise from high pressure in the upper sphincter.

In the American multi-test review, esophageal manometry found abnormalities in 62.8% of 172 people with isolated globus, the highest yield of any test examined. The joint society review urges caution, however: several throat, thyroid and esophageal disorders have been linked to globus, but cause and effect is hard to establish, and testing is often negative.

Stress, Anxiety and Low Mood

The connection with mood is one of the most consistent findings in globus research, although the direction of cause is not settled. In the 2026 global survey, anxiety and/or depression was present in 60.5% of people with globus.

A Korean case-control study compared 69 people whose globus had lasted 3 months or more despite anti-reflux medication with 62 controls. Abnormal anxiety scores were found in 46.4% of the globus group against 11.3% of controls, and abnormal depression scores in 55.1% against 17.7%.

Many readers find this kind of finding unwelcome, because it can sound like "it is all in your head." That is not what the research says. The Rome IV model describes nerves that signal at a lower threshold and a brain that pays closer attention to throat sensations; stress and anxiety can turn up both. The lump is felt, not imagined. The Anxiety page covers anxiety itself.

Thyroid and Structural Findings

The thyroid gland wraps around the front of the windpipe, close to where the lump is felt. A Turkish ultrasound study of 92 people being examined for thyroid problems found globus in 32 (35%) and ultrasound signs of chronic thyroiditis (long-term inflammation of the thyroid; see Hashimoto's thyroiditis) in 36 (39%). Globus was 3.7 times more likely in people with chronic thyroiditis (95% confidence interval 1.5 to 9.11), while thyroid volume and nodules were not related to it. The authors call it a preliminary report.

Thyroid surgery is a separate situation. A Japanese study followed 616 people having thyroid surgery. Before the operation, 29.4% reported neck discomfort above the study's threshold, and this was linked to higher depression scores rather than to the size of the thyroid. After surgery the share rose to 78.9% at one month and fell to 49.3% at 12 months, and a more extensive operation was linked to more lasting discomfort.

Other findings turn up in some people with globus:

Voice box findings. At an American laryngology practice, 228 people seen for globus had their vocal folds examined with a scope. Half had a normal exam; 25% had a vocal fold movement problem, 19% had a mass lesion on a vocal fold, and 3% had both. The authors suggest vocal fold problems may contribute to the sensation.
Gastric inlet patch. A small island of stomach-type lining in the upper esophagus (heterotopic gastric mucosa). Ablating it has been reported to improve globus; see Treating a Gastric Inlet Patch.
Post-nasal drip. A 2026 review in Mayo Clinic Proceedings lists sinus and nasal causes such as post-nasal drip among the processes that may contribute.

How Globus Is Investigated

There is no single agreed path. The Finnish review notes that because the cause is unclear, testing varies widely, which can expose patients to unnecessary investigations, and it proposes a stepwise approach. The tests that appear across the reviews are:

Laryngoscopy (nasolaryngoscopy). A thin flexible camera passed through the nose to look at the throat, the base of the tongue and the voice box. A 2026 review from Cedars-Sinai Medical Center describes it as the usual first test for isolated globus, followed by endoscopy. Doctors also use the view to grade signs of throat irritation with the Reflux Finding Score.
Upper endoscopy. A camera passed through the mouth to look at the esophagus and stomach, which can show inflammation, narrowing or an inlet patch. In the American multi-test review it found abnormalities in 22% of people with isolated globus.
Swallow studies. A barium swallow (esophagram) and the modified barium swallow (videofluoroscopy) film the swallow on X-ray. In the same review, the esophagram found abnormalities in 24%, while the modified barium swallow was normal in 93%.
High-resolution manometry. Pressure measurements along the esophagus, including the upper sphincter; abnormal in 62.8% in that review.
Ambulatory reflux monitoring. A 24-hour pH or pH-impedance test that counts reflux episodes; abnormal acid exposure in about 20% in that review.
Thyroid or neck ultrasound when the thyroid is suspected.

The joint society review lists laryngoscopy, endoscopy, high-resolution manometry, barium radiography and ambulatory reflux monitoring as the tests used to exclude other disorders before a diagnosis of idiopathic globus. It also states plainly that objective testing is often negative.

Features Clinicians Treat as Needing Prompt Evaluation

Most globus is benign, but the same throat sensation can occasionally come from something serious. The reviews identify a set of features that lead clinicians away from simple reassurance and toward testing:

Pain, including pain in the throat or neck.
Pain on swallowing (odynophagia).
True difficulty swallowing (dysphagia), where food sticks or catches.
Unexplained weight loss.
Hoarseness or a changed voice that persists, a voice-box symptom rather than a feature of globus itself; the laryngology study described above found vocal fold lesions in some people seen for globus.

The joint society review names pain, weight loss, dysphagia and odynophagia as indications for objective testing. The Cedars-Sinai review states that in people with globus and alarm symptoms, urgent nasolaryngoscopy and endoscopy are pursued. A British review notes that malignancy is "vanishingly rare" in the absence of red-flag symptoms and abnormal ENT examination findings.

The cancer question has been studied directly. An American study followed 377 people newly diagnosed with globus in 2015 for at least 4 years. Four developed a head and neck cancer, which the authors report as an overall incidence of 1% over 2015 to 2019, and they describe the risk as low. In the Irish study that followed 74 people for an average of 7 years and 7 months, no one developed a cancer of the upper aerodigestive tract (the mouth, throat, voice box and esophagus).

Acid Suppression Trials

The joint society review describes a trial of acid-suppressing treatment as reasonable when there are no alarm symptoms, especially when reflux symptoms are also present. The Cedars-Sinai review takes the same position for people who also have heartburn or regurgitation. Acid suppression usually means a proton pump inhibitor such as omeprazole, esomeprazole, pantoprazole or lansoprazole.

Results depend heavily on who is treated:

In a Dutch study, 101 people with globus took esomeprazole for 8 weeks. Responders were 43 (42.6%), partial responders 28 (27.7%) and non-responders 30 (29.7%). A high score on the Reflux Symptom Index questionnaire (above 13) and a high Reflux Finding Score on laryngoscopy (above 7) were each linked to response; among people with both, 95.5% reported a full or partial response.
In an American chart review of 87 people, 67% had a partial or complete response to aggressive reflux management. It was a retrospective study with no comparison group.
In the randomized trials described below, the proton pump inhibitor groups did worst. In a Thai trial, the omeprazole group improved by 0.21 points on the Glasgow Edinburgh Throat Scale against more than 6 points for the other two groups. In a Chinese trial in people whose globus had not responded to earlier treatment, 14.0% on lansoprazole met the response definition.

Read together, these studies suggest that acid suppression helps a subgroup whose globus comes with signs of reflux, and does little for globus without them. The 2026 systematic review reached the same overall picture: antidepressant-type drugs outperformed acid-suppressing comparators in controlled trials.

Neuromodulators: Low-Dose Antidepressants and Gabapentin

"Neuromodulator" is the term gut specialists use for drugs that act on nerve signalling, mostly antidepressants given at doses lower than those used for depression. The idea, in line with the Rome IV model, is to turn down oversensitive nerve signals from the throat.

Amitriptyline. In a Chinese trial of 34 people meeting Rome III criteria (30 completed), the trial gave 25 mg of amitriptyline at bedtime or 40 mg of pantoprazole daily for 4 weeks. Response, defined as more than a 50% fall in the Glasgow Edinburgh Throat Scale, was 75% with amitriptyline against 35.7% with pantoprazole. Sleep and several quality-of-life scores also improved more. The most common side effects were dry mouth, sleepiness, dizziness and constipation.

Paroxetine. A larger Chinese trial randomized people with globus that had not responded to earlier treatment to paroxetine, low-dose amitriptyline or high-dose lansoprazole for 6 weeks; 148 completed. Response rates were 71.7% (33 of 46) with paroxetine, 46.2% (24 of 52) with amitriptyline and 14.0% (7 of 50) with lansoprazole. Emotional well-being, quality of life and sleep improved most with paroxetine.

Flupenthixol with melitracen. The Thai trial gave 0.5 mg of flupenthixol and 10 mg of melitracen, a combination of two older psychiatric drugs, for 4 weeks. Its results appear in the next section beside the psychological treatment it was compared with. The drug group had more adverse events.

Gabapentin. Gabapentin is a nerve-pain and seizure drug. In the American chart review, 66% of people who tried it reported improvement, and 8 of 14 people who had not improved with reflux treatment improved with gabapentin. It was a retrospective review, not a trial.

What the US labels say. Globus is not among the uses on the US labels of any of these drugs, so their use for it is off-label. The amitriptyline label lists the relief of symptoms of depression. The paroxetine label lists major depressive disorder, obsessive compulsive disorder, panic disorder, social anxiety disorder, generalized anxiety disorder and posttraumatic stress disorder in adults. The gabapentin label lists postherpetic neuralgia in adults and add-on treatment of partial-onset seizures. Both antidepressant labels carry a warning that antidepressants increased the risk of suicidal thoughts and behaviors in children, adolescents and young adults in short-term studies; on the paroxetine label it is a boxed warning, and the label states that paroxetine tablets are not approved for use in children. Decisions about these medicines belong with a prescribing clinician.

Speech, Swallowing and Psychological Therapy

Psychological treatment. The Thai trial compared three 4-week treatments in people with globus: psychoeducation based on cognitive behavioural therapy (structured explanation and coping techniques), flupenthixol with melitracen, and omeprazole. Forty people completed it. On the Glasgow Edinburgh Throat Scale, the psychoeducation group improved by 6.46 points and the drug combination by 6.92 points, both significantly more than the 0.21 points with omeprazole. Changes in reflux symptoms, anxiety and depression scores and quality of life were similar across all three groups, and the drug combination caused more adverse events. The authors conclude that psychoeducation and the neuromodulators were equally effective in this small trial.

The 2026 systematic review, covering 15 studies with 784 people in total, found that psychological interventions produced benefit comparable to drugs with fewer adverse effects. It also found that reassurance and clinical attention on their own yielded symptom reduction comparable to active treatments, a reminder of how much the course of globus can change with explanation and time.

Speech and swallowing therapy. The speech-language pathology approaches studied for globus include explanation of the normal swallow, exercises to release tension in the throat and neck, voice exercises, relaxation and breathing work, posture advice, manual therapy, swallowing exercises and techniques for stopping habitual throat clearing. A 2024 scoping review screened 420 abstracts and found only five studies that met its criteria. All five reported significant improvement, but the reviewers concluded that there is very little high-quality evidence and that controlled studies are lacking. A Finnish study of 30 people found functional voice problems in 6 of the 23 examined by a speech-language pathologist (26%), and the authors suggest coexisting voice problems may be associated with globus that persists.

Other approaches. The same systematic review found short-term improvement with transcutaneous electroacupuncture and with stimulation of the vagus nerve through the ear in two small studies, which it describes as needing replication. It also describes small uncontrolled surgical series in which partial removal of the epiglottis, in people whose epiglottis touched the base of the tongue, was followed by symptom resolution.

Ban Xia Hou Po Tang, the Traditional Formula Containing Perilla

Traditional Chinese medicine has its own name for the lump-in-the-throat feeling: "plum pit qi", the sense of a plum stone stuck in the throat. The classical formula used for it is ban xia hou po tang (pinellia and magnolia bark decoction; hange-koboku-to in Japanese). Its ingredients include perilla leaf, alongside pinellia, magnolia bark, poria and ginger. The Perilla for Digestion page discusses the plant itself.

The 2025 Taiwanese trial. This single-blinded, placebo-controlled trial added either ban xia hou po tang or a placebo to a standard drug combination of fexofenadine (an antihistamine), famotidine (an acid-reducing drug) and acetylcysteine (a mucus-thinning drug) for 4 weeks. Ninety-two people completed it. Both groups improved on the Reflux Symptom Index, the Glasgow Edinburgh Throat Scale, the Reflux Finding Score and anxiety and depression scales. The group taking the formula had a lower Reflux Finding Score, meaning less visible throat irritation on laryngoscopy, at week 2 (8.03 against 10.12) and week 4 (7.43 against 9.17). No liver or kidney adverse effects occurred.

The 2010 Chinese trial. A trial in 95 people with "globus hystericus" compared a modified version of the formula (46 people) with a commercial throat-clearing granule (49 people). The outcome was a general psychological symptom questionnaire, and the formula group showed more relief of depression and anxiety. The trial did not report a throat-symptom score in its abstract.

These studies test a multi-herb formula, so a result cannot be attributed to perilla alone, and neither trial was double-blinded. In the 2025 trial, the formula's added benefit was seen on the doctor's view of the throat, while patient-reported symptom scores improved in both groups. The 2026 systematic review counted two traditional Chinese medicine studies among the 15 it assessed.

Treating a Gastric Inlet Patch

A gastric inlet patch is a small area of stomach-type lining in the upper, neck part of the esophagus. The joint society review notes that ablating heterotopic gastric mucosa in the upper esophagus has been reported to improve globus.

The best evidence comes from a randomized, sham-controlled multicenter trial led from Munich, Germany, in people with chronic globus and an inlet patch. The patch was destroyed with argon plasma coagulation, a heat treatment delivered through an endoscope, or a sham procedure was done instead. Symptoms improved in 9 of 11 people (82%) after real treatment and in none of 10 after the sham. Long-term benefit, at a median of 17 months, was documented in 13 of 17 treated people (76%).

A later study of the 49 people treated at the same Munich clinic assessed 31 of them and found the treatment successful in 23 of 31 (74%) after a median of 27 months, with symptom scores falling from 7.6 to 4.0 on a visual analogue scale. When 22 of them had a repeat endoscopy, 11 had a patch that had come back or had not been fully removed, and those people had a significant return of symptoms.

This treatment applies only to the minority of people with globus who have an inlet patch. By the Rome IV definition, a person whose symptoms come from an inlet patch does not have functional globus.

How Globus Changes Over Time

The joint society review describes globus as having a benign course with no long-term consequences, with a good overall prognosis because symptoms may decline over time. It also tends to linger or return.

Four months, no treatment. In the Finnish study, 30 people referred for globus had a full examination and testing but no treatment. After four months, their symptom questionnaire scores had fallen, and the authors report that most felt their symptoms had diminished.
About two years. In an Irish study of 80 people followed for an average of 27 months, 25% had no symptoms and a further 35% reported significant improvement. Being male, having had the symptom for less than 3 months before seeing a doctor, and having no other throat symptoms were linked to the best outcomes.
About seven and a half years. In the Irish follow-up of 74 people over an average of 7 years and 7 months, 55% were symptom-free and 45% still had symptoms. No feature at the first visit reliably predicted who would recover.

In short, the long-term studies show that globus resolves in some people and persists in others for years. Cancer was rare in the people followed: none in the Irish study of 74 people over about seven and a half years, and 4 of 377 in the American study over at least 4 years. The Irish authors note that some people developed other, unrelated conditions during follow-up.

What Is Not Known

The cause. Reflux, the upper sphincter, throat and thyroid findings and anxiety are all linked to globus in some studies, but the joint society review notes that cause and effect is hard to establish for any of them.
The best order of tests. Testing varies from clinic to clinic, and many tests come back normal.
Long-term drug results. The antidepressant trials lasted 4 to 6 weeks, were run in China and Thailand, and enrolled modest numbers of people. Few studies follow people for long after treatment ends.
Blinded comparisons for therapy. Speech therapy and psychological treatment have few controlled trials, and the systematic review found that attention and reassurance alone also help, which makes it hard to separate specific effects from general ones.
Herbal formulas. The trials of ban xia hou po tang are small, single-blinded or unblinded, and test several herbs at once.
Standard outcomes. The 2026 systematic review calls for larger trials with standardized criteria, validated outcome measures, attention-matched controls and long-term follow-up.

Key Research Papers

Zerbib F, Rommel N, Pandolfino J, Gyawali CP. ESNM/ANMS Review. Diagnosis and management of globus sensation: A clinical challenge. Neurogastroenterol Motil. 2020;32(9):e13850. PubMed PMID: 32329203
Aziz Q, Fass R, Gyawali CP, Miwa H, Pandolfino JE, Zerbib F. Functional Esophageal Disorders. Gastroenterology. 2016. PubMed PMID: 27144625
Raymenants K, Van de Bruaene C, Jandee S, Everaert M, Sperber AD, Palsson O, Bangdiwala SI, Khatun R, Rommel N, Vanuytsel T, Tack J. Putting Globus Into Context: Prevalence, Characteristics, and Overlap With Other Disorders of Gut-Brain Interaction. United European Gastroenterol J. 2026;14(7):e70277. PubMed PMID: 42610682
Järvenpää P, Arkkila P, Aaltonen LM. Globus pharyngeus: a review of etiology, diagnostics, and treatment. Eur Arch Otorhinolaryngol. 2018;275(8):1945-1953. PubMed PMID: 29943257
Chen FJ, Park JH. An approach to globus pharyngeus. Aust J Gen Pract. 2024;53(8):567-570. PubMed PMID: 39099124
Naik I, Vukkadala N, Kamboj AK. An Approach to Globus Sensation: Clinical Pearls for Clinicians. Mayo Clin Proc. 2026;101(7):1202-1210. PubMed PMID: 42383934
Siau R, Kinshuck A, Houghton L. The assessment and management of globus pharyngeus. Br J Hosp Med (Lond). 2021;82(3):1-8. PubMed PMID: 33792382
Rowley H, O'Dwyer TP, Jones AS, Timon CI. The natural history of globus pharyngeus. Laryngoscope. 1995;105(10):1118-21. PubMed PMID: 7564845
Timon C, O'Dwyer T, Cagney D, Walsh M. Globus pharyngeus: long-term follow-up and prognostic factors. Ann Otol Rhinol Laryngol. 1991;100(5 Pt 1):351-4. PubMed PMID: 2024895
Maronian N, Cabrera C, Dewey J, Meyer T. The Development of Head and Neck Cancer in Patients with the Isolated Complaint of Globus Pharyngeus. Laryngoscope. 2024;134(3):1147-1154. PubMed PMID: 37737553
Van Daele DJ. Esophageal Manometry, pH Testing, Endoscopy, and Videofluoroscopy in Patients With Globus Sensation. Laryngoscope. 2020;130(9):2120-2125. PubMed PMID: 31498462
Shires CB, Dewan K. Is there Really a Lump in My Throat? The Incidence and Implication of Vocal fold Abnormalities in Patients Presenting with Globus. J Voice. 2024;38(6):1419-1423. PubMed PMID: 35794058
Ding H, Duan Z, Yang D, Zhang Z, Wang L, Sun X, Yao Y, Lin X, Yang H, Wang S, Chen JDZ. High-resolution manometry in patients with and without globus pharyngeus and/or symptoms of laryngopharyngeal reflux. BMC Gastroenterol. 2017;17(1):109. PubMed PMID: 29061118
Kil HK, Kim HJ, Kim MS. Simple psychiatric screening for burning mouth syndrome and persistent globus pharyngeus using the hospital anxiety and depression scale: a case-control study. Braz J Otorhinolaryngol. 2026;93(1):101940. PubMed PMID: 42994149
Karahatay S, Ayan A, Aydin U, Ince S, Emer O, Alagoz E. The increased risk of globus pharyngeus in patients with chronic thyroiditis: a case control study. Eur Rev Med Pharmacol Sci. 2015;19(24):4722-7. PubMed PMID: 26744863
Tomoda C, Sugino K, Tanaka T, Ogimi Y, Masaki C, Akaishi J, Hames KY, Suzuki A, Matsuzu K, Uruno T, Ohkuwa K, Kitagawa W, Nagahama M, Ito K. Globus Symptoms in Patients Undergoing Thyroidectomy: Relationships with Psychogenic Factors, Thyroid Disease, and Surgical Procedure. Thyroid. 2018;28(1):104-109. PubMed PMID: 29183262
Boom L, Edens M, Rinia B. Reflux finding score and reflux symptom index as potential predictors for proton pump inhibitor response in globus pharyngeus patients: A prospective study. Auris Nasus Larynx. 2020;47(4):609-615. PubMed PMID: 32113831
Kim JE, Lee HJ, Kim MJ, Min YW, Rhee PL. Clinical Characteristics of Patients With Proton Pump Inhibitor-refractory Globus. J Neurogastroenterol Motil. 2025;31(2):210-217. PubMed PMID: 39622278
Kirch S, Gegg R, Johns MM, Rubin AD. Globus pharyngeus: effectiveness of treatment with proton pump inhibitors and gabapentin. Ann Otol Rhinol Laryngol. 2013;122(8):492-5. PubMed PMID: 24027858
You LQ, Liu J, Jia L, Jiang SM, Wang GQ. Effect of low-dose amitriptyline on globus pharyngeus and its side effects. World J Gastroenterol. 2013;19(42):7455-60. PubMed PMID: 24259978
Chen DY, Jia L, Gu X, Jiang SM, Xie HL, Xu J. Comparison of paroxetine and amitriptyline in the treatment of refractory globus pharyngeus. Dig Liver Dis. 2016;48(9):1012-7. PubMed PMID: 27378704
Poovipirom N, Ratta-Apha W, Maneerattanaporn M, Geeratragool T, Chuenprapai P, Leelakusolvong S. Treatment outcomes in patients with globus: A randomized control trial of psychoeducation, neuromodulators, and proton pump inhibitors. Neurogastroenterol Motil. 2023;35(3):e14500. PubMed PMID: 36443929
Iurina E, Kosonogov V. Therapeutic approaches for functional Globus Pharyngeus: A systematic review of studies from 2000 to 2025. Gen Hosp Psychiatry. 2026;102:1-13. PubMed PMID: 42372487
Ruckart KW, McKone M, Phillips JG, Krekelberg MO, Annalize Sussman K, Madden LL. Efficacy of Speech-Language Pathology Interventions for Globus Pharyngeus: A Scoping Review. J Voice. 2026;40(4):1102-1109. PubMed PMID: 38627105
Järvenpää P, Laatikainen A, Roine RP, Sintonen H, Arkkila P, Aaltonen LM. Symptom relief and health-related quality of life in globus patients: a prospective study. Logoped Phoniatr Vocol. 2019;44(2):67-72. PubMed PMID: 29119844
Yeh HF, Chu YS, Hwang SJ, Chen FP, Lu YT. Effects of Ban-Xia-Hou-Pu-Tang and Western medicine on patients with globus sensation: A randomized controlled trial. J Chin Med Assoc. 2025;88(12):941-948. PubMed PMID: 40241419
Bo P, Chen QM, Zhu HH, Zhang XD, Xu HR, Zhang Y, Cao YJ. Clinical observations on 46 cases of globus hystericus treated with modified Banxia Houpu decoction. J Tradit Chin Med. 2010;30(2):103-7. PubMed PMID: 20653165
Bajbouj M, Becker V, Eckel F, Miehlke S, Pech O, Prinz C, Schmid RM, Meining A. Argon plasma coagulation of cervical heterotopic gastric mucosa as an alternative treatment for globus sensations. Gastroenterology. 2009;137(2):440-4. PubMed PMID: 19410576
Klare P, Meining A, von Delius S, Wolf P, Konukiewitz B, Schmid RM, Bajbouj M. Argon plasma coagulation of gastric inlet patches for the treatment of globus sensation: it is an effective therapy in the long term. Digestion. 2013;88(3):165-71. PubMed PMID: 24157960

PubMed Topic Searches

Connections

ENT (Ear, Nose & Throat) — the parent section for throat conditions
Laryngopharyngeal Reflux (LPR) — reflux that reaches the throat and voice box
Dysphagia (Difficulty Swallowing) — the true swallowing problem globus is distinguished from
Sore Throat — painful throat symptoms and their causes
Gastroesophageal Reflux Disease (GERD) — reflux into the esophagus
Laryngitis and Voice Disorders — voice box findings that overlap with globus
Anxiety — the condition found most often alongside globus
Hashimoto's Thyroiditis — chronic thyroiditis and its link with globus
Functional Dyspepsia — another disorder of gut-brain interaction
Perilla for Digestion and Antimicrobial Use — the herb in ban xia hou po tang